查詢結果分析
來源資料
相關文獻
- 含Lansoprazole雙重或三合療法治療十二指腸潰瘍合併幽門螺旋桿菌感染之效果比較
- A Comparison of the Efficacy between Denol-Based and Zantac-Based Triple Therapy for Recurrent Duodenal Ulcer Accompanied with Helicobacter Pylori Infection
- 幽門螺旋桿菌之消除與消化性潰瘍之治療
- New One-Week, Low-Dose Triple Therapy for the Treatment of Duodenal Ulcer with Helicobacter Pylori Infection
- Lansoprazole三合療法與Bismuth三合療法對國人幽門曲狀桿菌陽性消化性潰瘍療效之比較
- The Role of Gastric Acid and Helicobacter Pylori in the Natural Course of Duodenal Ulcer
- Characteristics of Helicobacter Pylori Infection in Peptic Ulcer
- The Hemodynamic Changes of Gastroduodenal Regional Blood Flow after Helicobacter Pylorieradication in Patients with Duodenal Ulcer Scar
- The iceA1 and iceA2 Genotypes of Helicobactor pylori are Associated with the Duodenal Ulcer
- Follow-up of Helicobacter Pylori Status by Using 丨C-Urea Breath Test in Nonulcer Dyspeptic Patients after Eradication Therapy
頁籤選單縮合
題 名 | 含Lansoprazole雙重或三合療法治療十二指腸潰瘍合併幽門螺旋桿菌感染之效果比較=Comparison of Efficacy of Lansoprazole-based 2-wk Dual Therapy and 1-wk Triple Therapy in Patients with Duodenal Ulcer and Helicobacter Pylori Infection |
---|---|
作 者 | 周孫衍; 高進祿; 施壽全; 林錫全; 王鴻源; 張文熊; 朱正心; 王蒼恩; | 書刊名 | 內科學誌 |
卷 期 | 9:2 1998.06[民87.06] |
頁 次 | 頁76-81 |
分類號 | 415.5 |
關鍵詞 | 雙重療法; 三合療法; 幽門螺旋桿菌; 根除; 十二指腸潰瘍; Lansoprazole; Dual therapy; Triple therapy; Helicobacter pylori; Eradication; Duodenal ulcer; |
語 文 | 中文(Chinese) |
中文摘要 | 理想的幽門螺旋桿菌治療方法應該是高效率,簡單,便宜且副作用少。本研究係 以質子幫浦抑制劑Lansoprazole合併一種抗菌藥物(雙重療法)治療兩週與合併兩種抗菌藥 物(三合療法)治療一週,比較其在十二指腸潰瘍合併幽門螺旋桿菌感染的治療效果。以80 個證實為十二指腸潰瘍合併幽門螺旋桿菌感染的門診病人,隨機分為兩組,每組各為四十人。 雙重療法組服用Lansoprazole 30mg, Amoxicillin 1gm早晚各一次,服用兩週;三合療法組服 用Lansoprazole 30mg,Amoxicillin 1gm和Tinidazole 500mg早晚各一次,只服用一週。病人 停止服用上述藥物至少四週後,以快速尿素脢檢查及組織學檢查判定幽門螺旋桿菌的存在與 否。在雙重療法組40人中,36人完成治療與追蹤,21人幽門螺旋桿菌確實根除,以「意願 治療」分析,根除率為52.5%(21/40; 95% confidence interval = 37.0-68.0),以「按照計劃」分 析,根除率為58.3%(21/36; 95% confidence interval = 42.2-74.4),在治療法組40人中,37人 完成治療追蹤32人幽門螺旋桿菌確實根除。不管以「意願治療」或「按照計劃」分析統計, 一週的三合療法效率明顯優於兩週的雙重法(p<0.05),兩組的副作用率大至相似,而一週的 三合療法顯然比兩週的雙重療法簡單,便宜。 意願治療」或「按照計劃」分析統計,一週的三合 療法效率明顯優於兩週的雙重療法(p<0.05),兩組的副作用率大至相似,而一週的 三合療法顯然比兩週的雙重療法簡單,便宜。 |
英文摘要 | The ideal H. pylori treatment will be highly effective and cheap, with a short, simple regimen lacking in side efect. An open randomized study was designed to assess the effect of lansoprazole-based 2-wk dual therapy and 1-wk triple therapy on the eradication rates in Helicobacter pylori associated duodenal ulcer disease. Eighty patients with duodenal ulcer and H. pylori infection were randomly assigned t otwo treatment groups. Each group has 40 patients. Dual therapy (DT) group received lansoprazole 30mg b.d., amoxicillin 1gm b.d. for 2 weeks. Triple therapy (TT) group received lansoprazole 30mg b.d., amoxicillin 1gm b.d., and tnidazole 500mg b.d. for 1 week. At least 4 wk after treat mnent, H. pylori status was assessed by histology and rapid urease test. Thirty-six patients in DT group completed the tireatment and returmed for follow up. H. pylori was eradicated in 21 of 36 (58.3%; 95% confidence interval = 42.2-74.4) patients by per- protocol analysis, and in 21 of 40 (52.5%; 95% confidence interval = 37.0-68.0) patients by intent- to-treat analysis. Thirty-seven patients in TT group completed the treatment and retumed for follow up. H. pylori was eradicated in 32 of 37 (86.5%; 95% confidence interval = 75.5-97.5) patients by per-protocol analysis, and in 32 of 40 (80%; 95% confidence interval = 67.6-92.4) patients by intent- to-treat analysis. Triple therapy was significantly better than dual therapy in both intent-to-treat (P<0.05) and per protocol analysis (p<0.05). 1-wk lansoprazole-based triple therapy is more effective, more simple and cheaper than 2-wk lansoprazole-based dual therapy, and it does not increase the incidence of side effect. (J Intern Med Taiwan 1998; 9: 76-81) |
本系統中英文摘要資訊取自各篇刊載內容。